Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease

NCT02877251 | Unknown DMC

• 1 other identifier: REMMITE
• Study Type: observational
• Target: 500
• Locations: 0 countries
• Sites: N/A

Brief Summary

REMMITE, a retrospective and prospective registry with one-year follow-up, will provide valuable insights into the clinical diagnosis, management, treatment trends as well as related outcomes of three cohorts: DVT, DVT-PE, PE patients throughout many regions of Mexico and through different health care systems.

Conditions

Venous Thromboembolism; Venous Thrombosis; Pulmonary Embolism

Keywords

Venous Thromboembolism; Venous Thrombosis; Pulmonary Thromboembolism; National Registry; Mexico; Major Adverse Cardiovascular Events

Outcome Measures

Primary Outcomes (1)

• Major adverse cardiovascular events

  to identify clinical characteristics, treatment trends, in-hospital and 12 months follow-up outcome through major adverse cardiovascular events (MACE) of patients diagnosed either with DVT, DVT-PE, or PE.

  12 months

Study Arms (3)

Deep venous thrombosis

To identify clinical characteristics, treatment trends, in-hospital and 3, 6, and 12 months follow-up outcome through major adverse cardiovascular events (MACE) of patients diagnosed with deep venous thrombosis

Deep venous thrombosis and Pulmonary embolism

To identify clinical characteristics, treatment trends, in-hospital and 3, 6, and 12 months follow-up outcome through major adverse cardiovascular events (MACE) of patients diagnosed with deep venous thrombosis and pulmonary embolism

Pulmonary embolism

To identify clinical characteristics, treatment trends, in-hospital and 3, 6, and 12 months follow-up outcome through major adverse cardiovascular events (MACE) of patients diagnosed with pulmonary embolism

Eligibility Criteria

• Age: 18 Years - 99 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

DVT, DVT-PE, PE patients throughout many regions of Mexico and through different health care systems.

You may qualify if:

• patients older than 18 years;
• clinical diagnosis of DVT, DVT-PE, PE.

You may not qualify if:

• chronic DVT;
• chronic PE;
• refusal to participate.

Sponsors & Collaborators

• Registro Mexicano Multidisciplinario De Pacientes Con Enfermedad Tromboembolica Venosa: lead
• Webmedica: collaborator

MeSH Terms

Conditions

Venous Thromboembolism; Venous Thrombosis; Pulmonary Embolism

Condition Hierarchy (Ancestors)

Thromboembolism; Embolism and Thrombosis; Vascular Diseases; Cardiovascular Diseases; Thrombosis; Lung Diseases; Respiratory Tract Diseases; Embolism

Study Officials

• Pedro Gutierrez-Fajardo, MD

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Pedro Gutierrez-Fajardo, MD

CONTACT

+523338275177; drpedrogutierrez@yahoo.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Target Duration: 1 Year
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 12, 2016
• First Posted: August 24, 2016
• Study Start: December 1, 2023
• Primary Completion: May 1, 2024
• Study Completion: December 1, 2024
• Last Updated: June 10, 2022

Record last verified: 2022-06